784 VIRAL KINETICS MODELING TO PREDICT cEVR AND AID IN DOSE SELECTION DECISIONS FOR PHASE-2/3 CLINICAL TRIALS

Autor: Agarwal, A., Zhang, B., Robison, H., Robarge, L., Zhao, Y., Fabrycki, J., Patel, D., Yang, G., Huang, M., Hui, J., Kocinsky, H., Olek, E., Deshpande, M.
Zdroj: In Journal of Hepatology April 2013 58 Supplement 1:S319-S319
Databáze: ScienceDirect